{
    "Participant": "huCA14D2", 
    "Report URL": "http://evidence.personalgenomes.org/genomes?display_genome_id=737158fddaee3184191fdf8107edef0e678fda3c&access_token=342b20d406dc26a7fbddf837e5a949bd", 
    "Variants": [
        {
            "Allele Frequency": "0.14", 
            "Build 37 Chromosome": "chr19", 
            "Build 37 Position": "45411941", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "High", 
            "Condition Tags": [
                "Mental and behavioral", 
                "Nervous system"
            ], 
            "Evidence": "Well-established", 
            "Gene Symbol": "APOE", 
            "Impact": "Pathogenic", 
            "Inheritance": "Complex/Other", 
            "PMID Count": 4, 
            "PMID List": [
                "9343467", 
                "11950276", 
                "15123497", 
                "17428983"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "0", 
                "Familial": null, 
                "Functional": "3", 
                "Penetrance": "4", 
                "Severity": "4", 
                "Treatability": "2"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This is generally known as the ApoE4 allele of ApoE and is associated with increased risk of Alzheimer's. 20-25% of individuals are heterozygous for this variant, and 1-2% are homozygous. Data from Khachaturian et al. suggests an average 7% of all individuals developed Alzheimer's by the age of 80; when this is split by ApoE4 status: 10% of ApoE4 heterozygotes (3% increased attributable risk), 40% of ApoE4 homozygotes (33% increased attributable risk), and 5% of non-carriers (2% decreased attributable risk). Notably, their model suggests 70-75% of people would eventually develop Alzheimer's by the age of 100 regardless of ApoE4 genotype (and 25-30% are resistant, regardless of genotype), but that ApoE4 variants shift the disease onset to occur significantly earlier (4 years earlier for heterozygous carriers, 13 years for homozygotes).", 
            "URL": "http://evidence.pgp-hms.org/APOE-C130R", 
            "Variant Name": "APOE-C130R", 
            "Variant Page": "http://evidence.pgp-hms.org/APOE-C130R", 
            "dbSNP IDs": [
                "rs429358"
            ]
        }, 
        {
            "Allele Frequency": "0.048", 
            "Build 37 Chromosome": "chr20", 
            "Build 37 Position": "61451332", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Moderate", 
            "Condition Tags": [
                "Muscular, skeletal, and connective tissue"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "COL9A3", 
            "Impact": "Pathogenic", 
            "Inheritance": "Dominant", 
            "PMID Count": 1, 
            "PMID List": [
                "11308397"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "2", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "3", 
                "Severity": "3", 
                "Treatability": "2"
            }, 
            "Status": "Heterozygous", 
            "Summary": "Carriers of this collagen variant are associated with having a significantly increased risk of lumbar disc disease (~11% total risk compared to a typical risk of 4%). ", 
            "URL": "http://evidence.pgp-hms.org/COL9A3-R103W", 
            "Variant Name": "COL9A3-R103W", 
            "Variant Page": "http://evidence.pgp-hms.org/COL9A3-R103W", 
            "dbSNP IDs": [
                "rs61734651"
            ]
        }, 
        {
            "Allele Frequency": "0.0012", 
            "Build 37 Chromosome": "chr4", 
            "Build 37 Position": "6302799", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Moderate", 
            "Condition Tags": [
                "Mental and behavioral"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "WFS1", 
            "Impact": "Pathogenic", 
            "Inheritance": "Dominant", 
            "PMID Count": 2, 
            "PMID List": [
                "11244483", 
                "12955714"
            ], 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "1", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "3", 
                "Severity": "3", 
                "Treatability": "3"
            }, 
            "Status": "Heterozygous", 
            "Summary": "Reported in a single case of familial depression, but no linkage data and no statistical significance.", 
            "URL": "http://evidence.pgp-hms.org/WFS1-C426Y", 
            "Variant Name": "WFS1-C426Y", 
            "Variant Page": "http://evidence.pgp-hms.org/WFS1-C426Y", 
            "dbSNP IDs": [
                "rs35218685"
            ]
        }, 
        {
            "Allele Frequency": "0.0078", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Moderate", 
            "Condition Tags": [
                "Nervous system"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "FIG4", 
            "Impact": "Pathogenic", 
            "Inheritance": "Recessive", 
            "PMID Count": 0, 
            "Scores": {
                "Case/Control": null, 
                "Computational": "3", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "5", 
                "Severity": "3", 
                "Treatability": "2"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant is predicted to cause a frameshift and may cause Charcot-Marie-Tooth Disease Type 4J in an autosomal recessive manner. Other variants in this gene which cause frameshift and premature termination have been implicated in causing this disease when compound heterozygous with another FIG4 variant.", 
            "URL": "http://evidence.pgp-hms.org/FIG4-K278Shift", 
            "Variant Name": "FIG4-K278Shift", 
            "Variant Page": "http://evidence.pgp-hms.org/FIG4-K278Shift"
        }, 
        {
            "Allele Frequency": "0.04", 
            "Build 37 Chromosome": "chr11", 
            "Build 37 Position": "124530664", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Moderate", 
            "Condition Tags": [
                "Immune system"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "SIAE", 
            "Impact": "Pathogenic", 
            "Inheritance": "Recessive", 
            "PMID Count": 2, 
            "PMID List": [
                "20555325", 
                "22200769"
            ], 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "2", 
                "Familial": null, 
                "Functional": "2", 
                "Penetrance": "3", 
                "Severity": "3", 
                "Treatability": "3"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant was reported to be associated with autoimmune disease when homozygous. However, a later publication has contradicted this result, finding no significant association between this variant and autoimmune disease in a very large cohort.", 
            "URL": "http://evidence.pgp-hms.org/SIAE-M89V", 
            "Variant Name": "SIAE-M89V", 
            "Variant Page": "http://evidence.pgp-hms.org/SIAE-M89V", 
            "dbSNP IDs": [
                "rs78778622"
            ]
        }, 
        {
            "Allele Frequency": "0.32", 
            "Build 37 Chromosome": "chr13", 
            "Build 37 Position": "110818598", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Heart and circulatory"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "COL4A1", 
            "Impact": "Pathogenic", 
            "Inheritance": "Dominant", 
            "PMID Count": 3, 
            "PMID List": [
                "10334796", 
                "18077766", 
                "20031579"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "0", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "2", 
                "Severity": "4", 
                "Treatability": "4"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This common variant has been associated with arterial stiffness and, in Japanese, a small increased risk of myocardial infarction (MI, a.k.a. heart attack). This last observation supported a dominant effect for this variant and, assuming a lifetime risk of 15% for MI, we estimate carriers have an additional risk of 0.5-3%.", 
            "URL": "http://evidence.pgp-hms.org/COL4A1-Q1334H", 
            "Variant Name": "COL4A1-Q1334H", 
            "Variant Page": "http://evidence.pgp-hms.org/COL4A1-Q1334H", 
            "dbSNP IDs": [
                "rs3742207"
            ]
        }, 
        {
            "Allele Frequency": "0.45", 
            "Build 37 Chromosome": "chr5", 
            "Build 37 Position": "7870973", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Anatomical and congenital", 
                "Metabolism", 
                "Nervous system"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "MTRR", 
            "Impact": "Pathogenic", 
            "Inheritance": "Recessive", 
            "PMID Count": 7, 
            "PMID List": [
                "10444342", 
                "10930360", 
                "11807890", 
                "12375236", 
                "15060097", 
                "15979034", 
                "17024475"
            ], 
            "Scores": {
                "Case/Control": "3", 
                "Computational": "3", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "1", 
                "Severity": "4", 
                "Treatability": "2"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This common variant (HapMap allele frequency of 31.3%) in a protein involved in folate (B9) and cobalamin (B12) metabolism and is often reported as \"MTRR I22M\" (an alternative transcript position). Mothers homozygous for this variant are associated with having around a increased chance of a child with Down syndrome (risk of 0.4%, average risk in population is 0.25%). Notably, age plays a far larger role in the rate of Down syndrome (risk is 4.5% for a mother 45-years-of-age), and it is unknown how this variant may combine with the effect of age. There are conflicting reports associating this variant with incidence of neural tube defects, possibly when combined with MTHFR A222V.", 
            "URL": "http://evidence.pgp-hms.org/MTRR-I49M", 
            "Variant Name": "MTRR-I49M", 
            "Variant Page": "http://evidence.pgp-hms.org/MTRR-I49M", 
            "dbSNP IDs": [
                "rs1801394"
            ]
        }, 
        {
            "Allele Frequency": "0.1", 
            "Build 37 Chromosome": "chr10", 
            "Build 37 Position": "54531235", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Immune system"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "MBL2", 
            "Impact": "Pathogenic", 
            "Inheritance": "Recessive", 
            "PMID Count": 3, 
            "PMID List": [
                "7564730", 
                "10199352", 
                "17872904"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "2", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "3", 
                "Severity": "2", 
                "Treatability": "2"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant is associated with mannose binding protein deficiency which leads to impaired complement system immune response to mannose-rich pathogens. Patients homozygous for this allele or compound heterozygous are likely to have increased susceptibility to infection, but Hellemann et al. report heterosis for intensive care outcomes in heterozygous subjects. The wild-type version of this gene is known as variant allele A, while this is called variant allele B. See R52C (variant D) and G57E (variant C).", 
            "URL": "http://evidence.pgp-hms.org/MBL2-G54D", 
            "Variant Name": "MBL2-G54D", 
            "Variant Page": "http://evidence.pgp-hms.org/MBL2-G54D", 
            "dbSNP IDs": [
                "rs1800450"
            ]
        }, 
        {
            "Allele Frequency": "0.21", 
            "Build 37 Chromosome": "chr3", 
            "Build 37 Position": "148459988", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Drug response", 
                "Heart and circulatory"
            ], 
            "Evidence": "Likely", 
            "Impact": "Pathogenic", 
            "Inheritance": "Unknown", 
            "PMID Count": 6, 
            "PMID List": [
                "8021009", 
                "\n11250978", 
                "11593098", 
                "16046653", 
                "16675453", 
                "17668390"
            ], 
            "Scores": {
                "Case/Control": "3", 
                "Computational": "0", 
                "Familial": "0", 
                "Functional": "2", 
                "Penetrance": "2", 
                "Severity": "4", 
                "Treatability": "4"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This common noncoding genetic variant has an allele frequency of ~30% and is associated with an increased risk of hypertension. If ~25% of non-carriers have hypertension, Bonnardeaux et al's data predict ~4% increased risk of hypertension per copy of this variant. This SNP is in the 3' noncoding region of the AGTR1 transcript (angiotensin II type 1 receptor), also known as AT2R1 or AT1R, which is a target of hypertension drugs.", 
            "URL": "http://evidence.pgp-hms.org/rs5186", 
            "Variant Name": "rs5186", 
            "Variant Page": "http://evidence.pgp-hms.org/rs5186", 
            "dbSNP IDs": [
                "rs5186"
            ]
        }, 
        {
            "Allele Frequency": "0.044", 
            "Build 37 Chromosome": "chr1", 
            "Build 37 Position": "223285200", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Immune system"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "TLR5", 
            "Impact": "Pathogenic", 
            "Inheritance": "Complex/Other", 
            "PMID Count": 4, 
            "PMID List": [
                "14623910", 
                "16027372", 
                "17516623", 
                "18230059"
            ], 
            "Scores": {
                "Case/Control": "1", 
                "Computational": "1", 
                "Familial": null, 
                "Functional": "1", 
                "Penetrance": "1", 
                "Severity": "4", 
                "Treatability": "4"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant is believed to impair the ability to generate an immune response to the flagella of the bacteria. It is weakly associated with an increased incidence of Legionnaires' Disease, p = 0.085, increased lifetime risk of disease ~0.88% (about twice average). The variant is also weakly associated with a reduced incidence of systemic lupus erythematosus, p = 0.165.", 
            "URL": "http://evidence.pgp-hms.org/TLR5-R392X", 
            "Variant Name": "TLR5-R392X", 
            "Variant Page": "http://evidence.pgp-hms.org/TLR5-R392X", 
            "dbSNP IDs": [
                "rs5744168"
            ]
        }, 
        {
            "Allele Frequency": "0.28", 
            "Build 37 Chromosome": "chr1", 
            "Build 37 Position": "182554557", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Cancer", 
                "Genital and urinary"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "RNASEL", 
            "Impact": "Pathogenic", 
            "Inheritance": "Complex/Other", 
            "PMID Count": 4, 
            "PMID List": [
                "11941539", 
                "12022038", 
                "12415269", 
                "17407163"
            ], 
            "Scores": {
                "Case/Control": "2", 
                "Computational": "1", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "2", 
                "Severity": "4", 
                "Treatability": "4"
            }, 
            "Status": "Heterozygous", 
            "Summary": "Associated with increased risk of prostate cancer in individuals who already have a family history of prostate cancer, but studies have been unable to replicate this finding in sporadic (non-familial) prostate cancer cases.", 
            "URL": "http://evidence.pgp-hms.org/RNASEL-R462Q", 
            "Variant Name": "RNASEL-R462Q", 
            "Variant Page": "http://evidence.pgp-hms.org/RNASEL-R462Q", 
            "dbSNP IDs": [
                "rs486907"
            ]
        }, 
        {
            "Allele Frequency": "0.018", 
            "Build 37 Chromosome": "chr11", 
            "Build 37 Position": "134128923", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Metabolism"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "ACAD8", 
            "Impact": "Pathogenic", 
            "Inheritance": "Recessive", 
            "PMID Count": 2, 
            "PMID List": [
                "17304052", 
                "18677552"
            ], 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "1", 
                "Familial": null, 
                "Functional": "0", 
                "Penetrance": "0", 
                "Severity": "2", 
                "Treatability": "3"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant (a.k.a S149C) was found as a compound heterozygote (with M130T) in a male newborn of European descent with isobutyryl-CoA dehydrogenase deficiency (identified by newborn screening). Lack of controls means that significance cannot be established and allele frequency cannot be estimated. Oglesbee et al. comment that IBD-deficiency may be relatively benign, most cases identified by newborn screening have remained asymptomatic, but Ferreira et al. report a symptomatic individual homozygous for this variant.", 
            "URL": "http://evidence.pgp-hms.org/ACAD8-S171C", 
            "Variant Name": "ACAD8-S171C", 
            "Variant Page": "http://evidence.pgp-hms.org/ACAD8-S171C", 
            "dbSNP IDs": [
                "rs113488591"
            ]
        }, 
        {
            "Allele Frequency": "0.86", 
            "Build 37 Chromosome": "chr2", 
            "Build 37 Position": "231050715", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Immune system"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "SP110", 
            "Impact": "Pathogenic", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "16803959"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "0", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "1", 
                "Severity": "4", 
                "Treatability": "4"
            }, 
            "Status": "Homozygous", 
            "Summary": "This variant is associated with a slightly increased risk of tuberculosis. It is unclear whether it is itself causal, or in linkage disequilibrium with some other causal variant that has a stronger effect.", 
            "URL": "http://evidence.pgp-hms.org/SP110-L425S", 
            "Variant Name": "SP110-L425S", 
            "Variant Page": "http://evidence.pgp-hms.org/SP110-L425S", 
            "dbSNP IDs": [
                "rs3948464"
            ]
        }, 
        {
            "Allele Frequency": "0.63", 
            "Build 37 Chromosome": "chr17", 
            "Build 37 Position": "7579472", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Cancer"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "TP53", 
            "Impact": "Pathogenic", 
            "Inheritance": "Unknown", 
            "PMID Count": 6, 
            "PMID List": [
                "1975675", 
                "9607760", 
                "15355915", 
                "19837266", 
                "20615891", 
                "22184967"
            ], 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "3", 
                "Familial": null, 
                "Functional": "1", 
                "Penetrance": "0", 
                "Severity": "0", 
                "Treatability": "0"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This is a common variant was first reported as a polymorphism. It has since had mixed associations with cancer: Storey et al. conclude a 7x *increased* risk of HPV cancer for homozygotes vs hets, but Jones et al. find a 1.98x *decreased* risk for colorectal cancer. This variant may have significant impact on particular cancers, but it is unclear what effect it has on the overall burden of cancer.", 
            "URL": "http://evidence.pgp-hms.org/TP53-P72R", 
            "Variant Name": "TP53-P72R", 
            "Variant Page": "http://evidence.pgp-hms.org/TP53-P72R", 
            "dbSNP IDs": [
                "rs1042522"
            ]
        }, 
        {
            "Allele Frequency": "0.11", 
            "Build 37 Chromosome": "chr6", 
            "Build 37 Position": "26091179", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Blood"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "HFE", 
            "Impact": "Pathogenic", 
            "Inheritance": "Recessive", 
            "PMID Count": 5, 
            "PMID List": [
                "8696333", 
                "9462220", 
                "12429850", 
                "14673107", 
                "17042772"
            ], 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "2", 
                "Familial": "0", 
                "Functional": "2", 
                "Penetrance": "1", 
                "Severity": "4", 
                "Treatability": "5"
            }, 
            "Status": "Heterozygous", 
            "Summary": "There have been some hypotheses that this variant contributes to causing hereditary hemochromatosis, possibly as a compound heterozygote, but some others treat it as a polymorphism. Cys282Tyr is the classic causal variant and itself has very low penetrance. Mouse studies indicates this variant has a similar but weaker effect; if it has any effect at all its penetrance may be quite low and/or require modifier alleles.", 
            "URL": "http://evidence.pgp-hms.org/HFE-H63D", 
            "Variant Name": "HFE-H63D", 
            "Variant Page": "http://evidence.pgp-hms.org/HFE-H63D", 
            "dbSNP IDs": [
                "rs1799945"
            ]
        }, 
        {
            "Allele Frequency": "0.097", 
            "Build 37 Chromosome": "chr10", 
            "Build 37 Position": "96702047", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Moderate", 
            "Condition Tags": [
                "Drug response", 
                "Metabolism"
            ], 
            "Evidence": "Well-established", 
            "Gene Symbol": "CYP2C9", 
            "Impact": "Pharmacogenetic", 
            "Inheritance": "Unknown", 
            "PMID Count": 7, 
            "PMID List": [
                "8004131", 
                "15947090", 
                "17161452", 
                "17686967", 
                "19228618", 
                "19794411", 
                "19794412"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "2", 
                "Familial": null, 
                "Functional": "3", 
                "Penetrance": "3", 
                "Severity": "3", 
                "Treatability": "3"
            }, 
            "Status": "Homozygous", 
            "Summary": "This variant, also called CYP2C9*2, is a pharmacogenetic variant that modulates sensitivity for Warfarin (due to reduced metabolism). This variant is associated with Caucasians. The FDA has approved reduced recommended Warfarin dosage based on the presence of this variant.", 
            "URL": "http://evidence.pgp-hms.org/CYP2C9-R144C", 
            "Variant Name": "CYP2C9-R144C", 
            "Variant Page": "http://evidence.pgp-hms.org/CYP2C9-R144C", 
            "dbSNP IDs": [
                "rs1799853"
            ]
        }, 
        {
            "Allele Frequency": "0.35", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Impact": "Pharmacogenetic", 
            "Inheritance": "Unknown", 
            "PMID Count": 0, 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "1", 
                "Familial": "0", 
                "Functional": "-1", 
                "Penetrance": "0", 
                "Severity": "1", 
                "Treatability": "0"
            }, 
            "Status": "Heterozygous", 
            "Summary": "rs1544410 is a Vitamin D Receptor (VDR) single nucleotide polymorphism. It is unlikely that it has functional significance because it is located in an intron (Liu et. al.), but it is in strong linkage disequilibrium with rs731236 (Dvornyk et al), which is located in an exon. ", 
            "URL": "http://evidence.pgp-hms.org/rs1544410", 
            "Variant Name": "rs1544410", 
            "Variant Page": "http://evidence.pgp-hms.org/rs1544410", 
            "dbSNP IDs": [
                "rs1544410"
            ]
        }, 
        {
            "Allele Frequency": "0.49", 
            "Build 37 Chromosome": "chr19", 
            "Build 37 Position": "49206674", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Moderate", 
            "Condition Tags": [
                "Blood", 
                "Immune system"
            ], 
            "Evidence": "Well-established", 
            "Gene Symbol": "FUT2", 
            "Impact": "Protective", 
            "Inheritance": "Recessive", 
            "PMID Count": 5, 
            "PMID List": [
                "7876235", 
                "12692541", 
                "19625485", 
                "20031047", 
                "22025362"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "2", 
                "Familial": null, 
                "Functional": "2", 
                "Penetrance": "5", 
                "Severity": "2", 
                "Treatability": "3"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This recessive protective variant confers resistance to norovirus (which causes stomach flu). 20% of Caucasians and Africans are homozygous for this variant and are \"non-secretors\": they do not express ABO blood type antigens in their saliva or mucosal surfaces. Most strains of norovirus bind to these antigens in the gut, and so this non-secretor status confers almost total resistantance to most types of norovirus. There are notable exceptions, some strains of norovirus bind a different target and are equally infectious for secretors and non-secretors.", 
            "URL": "http://evidence.pgp-hms.org/FUT2-W154X", 
            "Variant Name": "FUT2-W154X", 
            "Variant Page": "http://evidence.pgp-hms.org/FUT2-W154X", 
            "dbSNP IDs": [
                "rs601338"
            ]
        }, 
        {
            "Allele Frequency": "0.34", 
            "Build 37 Chromosome": "chr20", 
            "Build 37 Position": "4680251", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Well-established", 
            "Gene Symbol": "PRNP", 
            "Impact": "Protective", 
            "Inheritance": "Complex/Other", 
            "PMID Count": 2, 
            "PMID List": [
                "18236005", 
                "19081515"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "3", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": "0", 
                "Severity": "4", 
                "Treatability": "1"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant is associated with some protective effects for prion disease -- individuals homozygous for this variant are less susceptible to Creutzfeldt-Jakob, and Papua New Guinea individuals heterozygotes at this site are less susceptible to kuru.\n\n", 
            "URL": "http://evidence.pgp-hms.org/PRNP-M129V", 
            "Variant Name": "PRNP-M129V", 
            "Variant Page": "http://evidence.pgp-hms.org/PRNP-M129V", 
            "dbSNP IDs": [
                "rs1799990"
            ]
        }, 
        {
            "Allele Frequency": "0.39", 
            "Build 37 Chromosome": "chr1", 
            "Build 37 Position": "196642233", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Hearing and vision", 
                "Metabolism"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "CFH", 
            "Impact": "Protective", 
            "Inheritance": "Complex/Other", 
            "PMID Count": 1, 
            "PMID List": [
                "15870199"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "1", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "2", 
                "Severity": "3", 
                "Treatability": "2"
            }, 
            "Status": "Heterozygous", 
            "Summary": "Associated with a decreased risk for age related macular degeneration (ARMD). Homozygotes for this have a 4-5% decreased attributable risk (3-4% vs. average 8% risk), heterozygotes have slightly lower than average risk (7%). Non-carriers have an increased risk (12-13%). ARMD impairs sharp vision as age progresses. While there is no cure, treatment can slow progression of the disease and environmental factors (smoking and obesity) contribute to higher risk.", 
            "URL": "http://evidence.pgp-hms.org/CFH-V62I", 
            "Variant Name": "CFH-V62I", 
            "Variant Page": "http://evidence.pgp-hms.org/CFH-V62I", 
            "dbSNP IDs": [
                "rs800292"
            ]
        }, 
        {
            "Allele Frequency": "0.3", 
            "Build 37 Chromosome": "chr18", 
            "Build 37 Position": "21140432", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Metabolism"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "NPC1", 
            "Impact": "Protective", 
            "Inheritance": "Complex/Other", 
            "PMID Count": 3, 
            "PMID List": [
                "19151714", 
                "19174833", 
                "19910939"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "2", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": "2", 
                "Severity": "3", 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant is associated with a reduced risk of obesity, with an additive effect of -0.084 BMI per allele (an average of 0.54 pounds less, per allele, in a 5'6\" individual).\n\n\n\n\n\n", 
            "URL": "http://evidence.pgp-hms.org/NPC1-H215R", 
            "Variant Name": "NPC1-H215R", 
            "Variant Page": "http://evidence.pgp-hms.org/NPC1-H215R", 
            "dbSNP IDs": [
                "rs1805081"
            ]
        }, 
        {
            "Allele Frequency": "0.74", 
            "Build 37 Chromosome": "chr11", 
            "Build 37 Position": "17409572", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Metabolism"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "KCNJ11", 
            "Impact": "Protective", 
            "Inheritance": "Unknown", 
            "PMID Count": 3, 
            "PMID List": [
                "17463246", 
                "17463248", 
                "20054294"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "1", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "2", 
                "Severity": "3", 
                "Treatability": "4"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant is associated with decreased risk of type 2 diabetes. It is unclear whether this variant has additive effects, or acts in a dominant or recessive manner. Assuming diabetes has a lifetime risk of 36%, we estimate a decreased risk of around 1-2% per copy of this variant.", 
            "URL": "http://evidence.pgp-hms.org/KCNJ11-K23E", 
            "Variant Name": "KCNJ11-K23E", 
            "Variant Page": "http://evidence.pgp-hms.org/KCNJ11-K23E", 
            "dbSNP IDs": [
                "rs5219"
            ]
        }, 
        {
            "Allele Frequency": "0.1", 
            "Build 37 Chromosome": "chr9", 
            "Build 37 Position": "132580901", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Nervous system"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "TOR1A", 
            "Impact": "Protective", 
            "Inheritance": "Unknown", 
            "PMID Count": 3, 
            "PMID List": [
                "18519876", 
                "19380705", 
                "20669276"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "2", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": "1", 
                "Severity": "1", 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "This SNP has been shown to be benign and play a protective role against Dystonia.  ", 
            "URL": "http://evidence.pgp-hms.org/TOR1A-D216H", 
            "Variant Name": "TOR1A-D216H", 
            "Variant Page": "http://evidence.pgp-hms.org/TOR1A-D216H", 
            "dbSNP IDs": [
                "rs1801968"
            ]
        }, 
        {
            "Allele Frequency": "0.035", 
            "Build 37 Chromosome": "chr6", 
            "Build 37 Position": "15523448", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Cancer"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "DTNBP1", 
            "Impact": "Protective", 
            "Inheritance": "Recessive", 
            "PMID Count": 1, 
            "PMID List": [
                "17000706"
            ], 
            "Scores": {
                "Case/Control": "2", 
                "Computational": "0", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "2", 
                "Severity": "3", 
                "Treatability": "3"
            }, 
            "Status": "Heterozygous", 
            "Summary": "Possibly a slight protective effect against colorectal cancer if homozygous.", 
            "URL": "http://evidence.pgp-hms.org/DTNBP1-P272S", 
            "Variant Name": "DTNBP1-P272S", 
            "Variant Page": "http://evidence.pgp-hms.org/DTNBP1-P272S", 
            "dbSNP IDs": [
                "rs17470454"
            ]
        }, 
        {
            "Allele Frequency": "0.2", 
            "Build 37 Chromosome": "chr11", 
            "Build 37 Position": "89017961", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Hearing and vision"
            ], 
            "Evidence": "Well-established", 
            "Gene Symbol": "TYR", 
            "Impact": "Benign", 
            "Inheritance": "Complex/Other", 
            "PMID Count": 7, 
            "PMID List": [
                "1820207", 
                "7704033", 
                "11284711", 
                "18326704", 
                "18488027", 
                "18488028", 
                "19533789"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "1", 
                "Familial": null, 
                "Functional": "2", 
                "Penetrance": "0", 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "This is a frequent pigmentation polymorphism in Europeans that affects function of the Tyrosinase gene. It is associated with blue instead of green eyes and sun sensitivity. For the most part this variant is benign, but many individuals with ocular albinism (which affects only the eyes) carry this variant along with another more severe variant in the same gene.", 
            "URL": "http://evidence.pgp-hms.org/TYR-R402Q", 
            "Variant Name": "TYR-R402Q", 
            "Variant Page": "http://evidence.pgp-hms.org/TYR-R402Q", 
            "dbSNP IDs": [
                "rs1126809"
            ]
        }, 
        {
            "Allele Frequency": "0.017", 
            "Build 37 Chromosome": "chr2", 
            "Build 37 Position": "74757554", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Nervous system"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "HTRA2", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 2, 
            "PMID List": [
                "15961413", 
                "18364387"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "1", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Probably benign. One report proposed an association with increased risk for Parkinson's disease, but had very weak statistical significance. A later study found an equal incidence of this variant in cases and controls, contradicting any association with the disease.", 
            "URL": "http://evidence.pgp-hms.org/HTRA2-A141S", 
            "Variant Name": "HTRA2-A141S", 
            "Variant Page": "http://evidence.pgp-hms.org/HTRA2-A141S", 
            "dbSNP IDs": [
                "rs72470544"
            ]
        }, 
        {
            "Allele Frequency": "0.018", 
            "Build 37 Chromosome": "chr1", 
            "Build 37 Position": "237778082", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Heart and circulatory", 
                "Muscular, skeletal, and connective tissue", 
                "Nervous system"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "RYR2", 
            "Impact": "Benign", 
            "Inheritance": "Recessive", 
            "PMID Count": 2, 
            "PMID List": [
                "16769042", 
                "18326664"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "0", 
                "Familial": "0", 
                "Functional": "0", 
                "Penetrance": "0", 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Hypothesized to cause arrhythmogenic right ventricular cardiomyopathy when compound heterozygous with G1886S. However, this variant is quite common (2.4% in Europeans), as is G1886S (3.1% in Europeans), and about 1 in 700 are compound heterozygous. This is highly discordant with a disease prevalence of 1 in 2500 to 5000, and notably G1886S is reported in ClinVar as benign. We should consider the original hypothesis disproven.", 
            "URL": "http://evidence.pgp-hms.org/RYR2-G1885E", 
            "Variant Name": "RYR2-G1885E", 
            "Variant Page": "http://evidence.pgp-hms.org/RYR2-G1885E", 
            "dbSNP IDs": [
                "rs41315858"
            ]
        }, 
        {
            "Allele Frequency": "0.044", 
            "Build 37 Chromosome": "chr6", 
            "Build 37 Position": "52303361", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Nervous system"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "EFHC1", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 2, 
            "PMID List": [
                "7668263", 
                "15258581"
            ], 
            "Scores": {
                "Case/Control": "3", 
                "Computational": "1", 
                "Familial": null, 
                "Functional": "1", 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Probably benign. OMIM appears to incorrectly interpret literature as linking this variant to juvenile myoclonic epilepsy; the authors report it as a polymorphism.", 
            "URL": "http://evidence.pgp-hms.org/EFHC1-R182H", 
            "Variant Name": "EFHC1-R182H", 
            "Variant Page": "http://evidence.pgp-hms.org/EFHC1-R182H", 
            "dbSNP IDs": [
                "rs3804505"
            ]
        }, 
        {
            "Allele Frequency": "0.27", 
            "Build 37 Chromosome": "chr1", 
            "Build 37 Position": "201052310", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "CACNA1S", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 0, 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "1", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Common polymorphism", 
            "URL": "http://evidence.pgp-hms.org/CACNA1S-L458H", 
            "Variant Name": "CACNA1S-L458H", 
            "Variant Page": "http://evidence.pgp-hms.org/CACNA1S-L458H", 
            "dbSNP IDs": [
                "rs12742169"
            ]
        }, 
        {
            "Allele Frequency": "0.013", 
            "Build 37 Chromosome": "chr6", 
            "Build 37 Position": "51484226", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "PKHD1", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "15698423"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "1", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Probably benign, reported as a nonpathogenic polymorphism found in controls.", 
            "URL": "http://evidence.pgp-hms.org/PKHD1-V3960I", 
            "Variant Name": "PKHD1-V3960I", 
            "Variant Page": "http://evidence.pgp-hms.org/PKHD1-V3960I", 
            "dbSNP IDs": [
                "rs34548196"
            ]
        }, 
        {
            "Allele Frequency": "0.049", 
            "Build 37 Chromosome": "chr6", 
            "Build 37 Position": "51491866", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "PKHD1", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 0, 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "0", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Presumed benign, allele frequency contradicts severe pathogenic effect.", 
            "URL": "http://evidence.pgp-hms.org/PKHD1-I3905N", 
            "Variant Name": "PKHD1-I3905N", 
            "Variant Page": "http://evidence.pgp-hms.org/PKHD1-I3905N", 
            "dbSNP IDs": [
                "rs2661488"
            ]
        }, 
        {
            "Allele Frequency": "0.37", 
            "Build 37 Chromosome": "chr7", 
            "Build 37 Position": "6026988", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "PMS2", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "15256438"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "1", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Homozygous", 
            "Summary": "Benign, common variant.", 
            "URL": "http://evidence.pgp-hms.org/PMS2-P470S", 
            "Variant Name": "PMS2-P470S", 
            "Variant Page": "http://evidence.pgp-hms.org/PMS2-P470S", 
            "dbSNP IDs": [
                "rs1805321"
            ]
        }, 
        {
            "Allele Frequency": "0.21", 
            "Build 37 Chromosome": "chr17", 
            "Build 37 Position": "7906519", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Hearing and vision"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "GUCY2D", 
            "Impact": "Benign", 
            "Inheritance": "Recessive", 
            "PMID Count": 1, 
            "PMID List": [
                "8944027"
            ], 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "1", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Homozygous", 
            "Summary": "One publication suggested that this variant possibly causes Leber's congenital amaurosis in a recessive manner, but the frequency data (36% in 1000 genomes) contradicts any significant pathogenic effect.", 
            "URL": "http://evidence.pgp-hms.org/GUCY2D-A52S", 
            "Variant Name": "GUCY2D-A52S", 
            "Variant Page": "http://evidence.pgp-hms.org/GUCY2D-A52S", 
            "dbSNP IDs": [
                "rs61749665"
            ]
        }, 
        {
            "Allele Frequency": "0.24", 
            "Build 37 Chromosome": "chr3", 
            "Build 37 Position": "37053568", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "MLH1", 
            "Impact": "Benign", 
            "Inheritance": "Dominant", 
            "PMID Count": 8, 
            "PMID List": [
                "11781295", 
                "12810663", 
                "17074586", 
                "17510385", 
                "17870204", 
                "19863800", 
                "20301390", 
                "22631669"
            ], 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "0", 
                "Familial": null, 
                "Functional": "0", 
                "Penetrance": "0", 
                "Severity": "0", 
                "Treatability": "0"
            }, 
            "Status": "Heterozygous", 
            "Summary": "Computational evidence, functional assays, and case/control studies suggest this variant is probably benign.", 
            "URL": "http://evidence.pgp-hms.org/MLH1-I219V", 
            "Variant Name": "MLH1-I219V", 
            "Variant Page": "http://evidence.pgp-hms.org/MLH1-I219V", 
            "dbSNP IDs": [
                "rs1799977"
            ]
        }, 
        {
            "Allele Frequency": "0.23", 
            "Build 37 Chromosome": "chr14", 
            "Build 37 Position": "21790040", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Hearing and vision"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "RPGRIP1", 
            "Impact": "Benign", 
            "Inheritance": "Complex/Other", 
            "PMID Count": 2, 
            "PMID List": [
                "12920076", 
                "16272259"
            ], 
            "Scores": {
                "Case/Control": "1", 
                "Computational": "2", 
                "Familial": "-1", 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Probably benign. Implicated in causing autosomal recessive cone-rod dystrophy, but a later report found the same incidence in controls and concludes it is not causal.", 
            "URL": "http://evidence.pgp-hms.org/RPGRIP1-A547S", 
            "Variant Name": "RPGRIP1-A547S", 
            "Variant Page": "http://evidence.pgp-hms.org/RPGRIP1-A547S", 
            "dbSNP IDs": [
                "rs10151259"
            ]
        }, 
        {
            "Allele Frequency": "0.048", 
            "Build 37 Chromosome": "chr16", 
            "Build 37 Position": "28950051", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "CD19", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 0, 
            "Scores": {
                "Case/Control": "1", 
                "Computational": "-1", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Presumed benign.", 
            "URL": "http://evidence.pgp-hms.org/CD19-R514H", 
            "Variant Name": "CD19-R514H", 
            "Variant Page": "http://evidence.pgp-hms.org/CD19-R514H", 
            "dbSNP IDs": [
                "rs34763945"
            ]
        }, 
        {
            "Allele Frequency": "0.023", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Heart and circulatory"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "RNASEH2B", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "16845400"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "-1", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant is predicted to be highly disruptive. Although other disruptive variants in this gene are reported to cause Aicardi-Goutieres syndrome in a recessive manner (a rare, fatal childhood disease), those variants were upstream of this position, and this variant is too common to be consistent with causing that disease (2% allele frequency). Based on this, it is tentatively evaluated as benign.", 
            "URL": "http://evidence.pgp-hms.org/RNASEH2B-I309Shift", 
            "Variant Name": "RNASEH2B-I309Shift", 
            "Variant Page": "http://evidence.pgp-hms.org/RNASEH2B-I309Shift"
        }, 
        {
            "Allele Frequency": "1.0", 
            "Build 37 Chromosome": "chr2", 
            "Build 37 Position": "21235475", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "APOB", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 0, 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "5", 
                "Familial": "0", 
                "Functional": "0", 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Homozygous", 
            "Summary": "This position is almost certainly an error in the HG18 reference sequence. ", 
            "URL": "http://evidence.pgp-hms.org/APOB-Y1422C", 
            "Variant Name": "APOB-Y1422C", 
            "Variant Page": "http://evidence.pgp-hms.org/APOB-Y1422C", 
            "dbSNP IDs": [
                "rs568413"
            ]
        }, 
        {
            "Allele Frequency": "0.046", 
            "Build 37 Chromosome": "chr12", 
            "Build 37 Position": "6061559", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "VWF", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "11439975"
            ], 
            "Scores": {
                "Case/Control": "1", 
                "Computational": "-1", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Homozygous", 
            "Summary": "Probably benign, seems to be considered an uncommon polymorphism.", 
            "URL": "http://evidence.pgp-hms.org/VWF-G2705R", 
            "Variant Name": "VWF-G2705R", 
            "Variant Page": "http://evidence.pgp-hms.org/VWF-G2705R", 
            "dbSNP IDs": [
                "rs7962217"
            ]
        }, 
        {
            "Allele Frequency": "0.0032", 
            "Build 37 Chromosome": "chr18", 
            "Build 37 Position": "2929103", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Blood", 
                "Muscular, skeletal, and connective tissue", 
                "Skin"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "LPIN2", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 0, 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "0", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Unreported and rare, tentatively evaluated as benign. Other recessive mutations in this gene cause Majeed syndrome (multifocal osteomyelitis, anemia, and dermatosis). Although unstudied, LPIN2 is in a locus associated with psoriasis.", 
            "URL": "http://evidence.pgp-hms.org/LPIN2-L504F", 
            "Variant Name": "LPIN2-L504F", 
            "Variant Page": "http://evidence.pgp-hms.org/LPIN2-L504F", 
            "dbSNP IDs": [
                "rs104895500"
            ]
        }, 
        {
            "Allele Frequency": "0.27", 
            "Build 37 Chromosome": "chr11", 
            "Build 37 Position": "88911696", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Skin"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "TYR", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 2, 
            "PMID List": [
                "17952075", 
                "17999355"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "2", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant is reported to affect skin pigmentation. It is associated with lighter skin in South Asians (OR 4-5) and with a lack of freckles in Europeans (OR 1.3).", 
            "URL": "http://evidence.pgp-hms.org/TYR-S192Y", 
            "Variant Name": "TYR-S192Y", 
            "Variant Page": "http://evidence.pgp-hms.org/TYR-S192Y", 
            "dbSNP IDs": [
                "rs1042602"
            ]
        }, 
        {
            "Allele Frequency": "0.46", 
            "Build 37 Chromosome": "chr7", 
            "Build 37 Position": "141672604", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "TAS2R38", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 2, 
            "PMID List": [
                "12595690", 
                "20675712"
            ], 
            "Scores": {
                "Case/Control": "2", 
                "Computational": "2", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Homozygous", 
            "Summary": "This variant is associated with \"taster\" status of PTC, along with 49P and 262A. Due to linkage disequilibrium, the independent effects of positions 296 and 262 is unclear. The presence of 49P confers taster status in a dominant fashion, but in the absence of 49P, the presence of 262A/296V is still positively associated with tasting PTC.", 
            "URL": "http://evidence.pgp-hms.org/TAS2R38-I296V", 
            "Variant Name": "TAS2R38-I296V", 
            "Variant Page": "http://evidence.pgp-hms.org/TAS2R38-I296V", 
            "dbSNP IDs": [
                "rs10246939"
            ]
        }, 
        {
            "Allele Frequency": "0.3", 
            "Build 37 Chromosome": "chr9", 
            "Build 37 Position": "98209594", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "PTCH1", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "15712338"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "-1", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Common polymorphism, presumed benign.", 
            "URL": "http://evidence.pgp-hms.org/PTCH1-P1315L", 
            "Variant Name": "PTCH1-P1315L", 
            "Variant Page": "http://evidence.pgp-hms.org/PTCH1-P1315L", 
            "dbSNP IDs": [
                "rs357564"
            ]
        }, 
        {
            "Allele Frequency": "0.16", 
            "Build 37 Chromosome": "chr17", 
            "Build 37 Position": "44061278", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "MAPT", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "15365985"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "-1", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Probably benign.", 
            "URL": "http://evidence.pgp-hms.org/MAPT-R370W", 
            "Variant Name": "MAPT-R370W", 
            "Variant Page": "http://evidence.pgp-hms.org/MAPT-R370W", 
            "dbSNP IDs": [
                "rs17651549"
            ]
        }, 
        {
            "Allele Frequency": "0.89", 
            "Build 37 Chromosome": "chr1", 
            "Build 37 Position": "55529187", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "PCSK9", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "19351729"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "3", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Homozygous", 
            "Summary": "This variant is likely benign. ", 
            "URL": "http://evidence.pgp-hms.org/PCSK9-G670E", 
            "Variant Name": "PCSK9-G670E", 
            "Variant Page": "http://evidence.pgp-hms.org/PCSK9-G670E", 
            "dbSNP IDs": [
                "rs505151"
            ]
        }, 
        {
            "Allele Frequency": "0.024", 
            "Build 37 Chromosome": "chr16", 
            "Build 37 Position": "23641461", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "PALB2", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "17200668"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "0", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Probably benign.", 
            "URL": "http://evidence.pgp-hms.org/PALB2-E672Q", 
            "Variant Name": "PALB2-E672Q", 
            "Variant Page": "http://evidence.pgp-hms.org/PALB2-E672Q", 
            "dbSNP IDs": [
                "rs45532440"
            ]
        }, 
        {
            "Allele Frequency": "0.0078", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Immune system", 
                "Nervous system", 
                "Skin"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "LYST", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 0, 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "0", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Rare and unreported, tentatively evaluated as benign. Some severe mutations in this gene cause Chediak-Higashi syndrome (a severe genetic disorder causing albinism, neuropathy, and life-threatening susceptibility to bacterial infections), but this disease is rare and there are many other genomes with rare missense polymorphisms.", 
            "URL": "http://evidence.pgp-hms.org/LYST-R159K", 
            "Variant Name": "LYST-R159K", 
            "Variant Page": "http://evidence.pgp-hms.org/LYST-R159K", 
            "dbSNP IDs": [
                "rs111806240"
            ]
        }, 
        {
            "Allele Frequency": "0.35", 
            "Build 37 Chromosome": "chr8", 
            "Build 37 Position": "55539395", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Metabolism"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "RP1", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 2, 
            "PMID List": [
                "12764676", 
                "19364639"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "-1", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Homozygous", 
            "Summary": "Probably benign. One report linked this variant to high triglycerides, but a later paper found a nearby SNP with similar association and suggests that both findings are caused by linkage to an undiscovered causal variant.", 
            "URL": "http://evidence.pgp-hms.org/RP1-N985Y", 
            "Variant Name": "RP1-N985Y", 
            "Variant Page": "http://evidence.pgp-hms.org/RP1-N985Y", 
            "dbSNP IDs": [
                "rs2293869"
            ]
        }, 
        {
            "Allele Frequency": "0.29", 
            "Build 37 Chromosome": "chr11", 
            "Build 37 Position": "68855363", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "TPCN2", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "18488028"
            ], 
            "Scores": {
                "Case/Control": "2", 
                "Computational": "1", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": "0"
            }, 
            "Status": "Heterozygous", 
            "Summary": "Pigmentation allele.", 
            "URL": "http://evidence.pgp-hms.org/TPCN2-G734E", 
            "Variant Name": "TPCN2-G734E", 
            "Variant Page": "http://evidence.pgp-hms.org/TPCN2-G734E", 
            "dbSNP IDs": [
                "rs3829241"
            ]
        }, 
        {
            "Allele Frequency": "0.11", 
            "Build 37 Chromosome": "chr1", 
            "Build 37 Position": "152276772", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Skin"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "FLG", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 0, 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "-1", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Tentatively classified as benign, although predicted by Polyphen 2 to be damaging. Other more severe null mutations (frameshift and nonsense) in this gene are reported to cause ichthyosis vulgaris in a recessive manner.", 
            "URL": "http://evidence.pgp-hms.org/FLG-R3530S", 
            "Variant Name": "FLG-R3530S", 
            "Variant Page": "http://evidence.pgp-hms.org/FLG-R3530S", 
            "dbSNP IDs": [
                "rs72697000"
            ]
        }, 
        {
            "Allele Frequency": "0.43", 
            "Build 37 Chromosome": "chr7", 
            "Build 37 Position": "141673345", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "TAS2R38", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 3, 
            "PMID List": [
                "12595690", 
                "15883422", 
                "20675712"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "1", 
                "Familial": "5", 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Homozygous", 
            "Summary": "This variant is strongly associated with causing the \"taster\" phenotype of phenylthiocarbamine (PTC) in a dominant manner.", 
            "URL": "http://evidence.pgp-hms.org/TAS2R38-A49P", 
            "Variant Name": "TAS2R38-A49P", 
            "Variant Page": "http://evidence.pgp-hms.org/TAS2R38-A49P", 
            "dbSNP IDs": [
                "rs713598"
            ]
        }, 
        {
            "Allele Frequency": "0.69", 
            "Build 37 Chromosome": "chr5", 
            "Build 37 Position": "33951693", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Cancer"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "SLC45A2", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 4, 
            "PMID List": [
                "15714523", 
                "17044855", 
                "18563784", 
                "18806926"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": null, 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": "0", 
                "Treatability": "0"
            }, 
            "Status": "Homozygous", 
            "Summary": "Pigmentation allele for non-black hair, and consequently, possible increased susceptibility to malignant melanoma.", 
            "URL": "http://evidence.pgp-hms.org/SLC45A2-L374F", 
            "Variant Name": "SLC45A2-L374F", 
            "Variant Page": "http://evidence.pgp-hms.org/SLC45A2-L374F", 
            "dbSNP IDs": [
                "rs16891982"
            ]
        }, 
        {
            "Allele Frequency": "0.038", 
            "Build 37 Chromosome": "chr7", 
            "Build 37 Position": "37923923", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Anatomical and congenital", 
                "Breathing"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "TXNDC3", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 0, 
            "Scores": {
                "Case/Control": "1", 
                "Computational": "-1", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Tentatively classified as benign, but predicted to be damaging and other variants in this gene are implicated in causing primary ciliary dyskinesia (situs inversus, chronic sinusitis, and bronchiectasis).", 
            "URL": "http://evidence.pgp-hms.org/TXNDC3-I338T", 
            "Variant Name": "TXNDC3-I338T", 
            "Variant Page": "http://evidence.pgp-hms.org/TXNDC3-I338T", 
            "dbSNP IDs": [
                "rs62001870"
            ]
        }
    ]
}